BR112017006349A2 - derivados de ácido borônico - Google Patents
derivados de ácido borônicoInfo
- Publication number
- BR112017006349A2 BR112017006349A2 BR112017006349A BR112017006349A BR112017006349A2 BR 112017006349 A2 BR112017006349 A2 BR 112017006349A2 BR 112017006349 A BR112017006349 A BR 112017006349A BR 112017006349 A BR112017006349 A BR 112017006349A BR 112017006349 A2 BR112017006349 A2 BR 112017006349A2
- Authority
- BR
- Brazil
- Prior art keywords
- acid derivatives
- boronic acid
- employed
- compounds
- formula
- Prior art date
Links
- 150000001642 boronic acid derivatives Chemical class 0.000 title 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 206010066476 Haematological malignancy Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14003391 | 2014-10-01 | ||
| PCT/EP2015/001931 WO2016050356A1 (en) | 2014-10-01 | 2015-10-01 | Boronic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112017006349A2 true BR112017006349A2 (pt) | 2017-12-12 |
Family
ID=51690788
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112017006349A BR112017006349A2 (pt) | 2014-10-01 | 2015-10-01 | derivados de ácido borônico |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10253049B2 (enExample) |
| EP (1) | EP3201208B1 (enExample) |
| JP (1) | JP6896618B2 (enExample) |
| KR (1) | KR20170062518A (enExample) |
| CN (1) | CN107074885B (enExample) |
| AU (1) | AU2015327412B2 (enExample) |
| BR (1) | BR112017006349A2 (enExample) |
| CA (1) | CA2963198A1 (enExample) |
| ES (1) | ES2876287T3 (enExample) |
| IL (1) | IL251299A0 (enExample) |
| MX (1) | MX2017004043A (enExample) |
| RU (1) | RU2017115191A (enExample) |
| SG (1) | SG11201702620SA (enExample) |
| WO (1) | WO2016050356A1 (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2873000T3 (es) | 2014-10-01 | 2021-11-03 | Merck Patent Gmbh | Derivados del ácido borónico. |
| JP6662865B2 (ja) | 2014-10-01 | 2020-03-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ボロン酸誘導体 |
| CN107108660B (zh) | 2014-10-01 | 2020-09-15 | 默克专利股份公司 | 硼酸衍生物 |
| DK3571208T3 (da) * | 2017-01-18 | 2021-05-10 | Principia Biopharma Inc | Immunproteasominhibitorer |
| IL272806B2 (en) | 2017-08-24 | 2023-09-01 | Merck Patent Gmbh | The history of boronic acid, its preparation and pharmaceutical preparations containing it |
| US20200276204A1 (en) | 2017-09-21 | 2020-09-03 | Kezar Life Sciences | Combination therapy for immunological diseases |
| CN112469480A (zh) | 2018-07-26 | 2021-03-09 | 默克专利股份公司 | 硼酸衍生物 |
| CN113135943A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
| CN113135944A (zh) * | 2020-01-19 | 2021-07-20 | 首药控股(北京)有限公司 | 硼酸衍生物 |
| CA3227452A1 (en) | 2021-07-29 | 2023-02-02 | Merck Patent Gmbh | Novel crystalline forms of [(1r)-2-(1-benzofuran-3-yl)-1-{[(1s,2r,4r)-7- oxabicyclo[2.2.1]heptan-2-yl]formamido}ethyl]boronic acid, adducts thereof, and processes to obtain |
| WO2023061445A1 (zh) * | 2021-10-14 | 2023-04-20 | 首药控股(北京)股份有限公司 | 硼酸衍生物 |
| CN117003776A (zh) * | 2022-04-29 | 2023-11-07 | 科辉智药生物科技(深圳)有限公司 | 一种硼酸类蛋白酶体抑制剂及其用途 |
| WO2023232830A1 (en) | 2022-06-02 | 2023-12-07 | Merck Patent Gmbh | Boronic acid adducts |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL111175A0 (en) * | 1993-10-07 | 1994-12-29 | Du Pont Merck Pharma | Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them |
| US6083903A (en) * | 1994-10-28 | 2000-07-04 | Leukosite, Inc. | Boronic ester and acid compounds, synthesis and uses |
| AU5788800A (en) * | 1999-07-07 | 2001-01-22 | Du Pont Pharmaceuticals Company | Peptide boronic acid inhibitors of hepatitis c virus protease |
| EP1863513A2 (en) * | 2005-03-11 | 2007-12-12 | The University of North Carolina at Chapel Hill | Potent and specific immunoproteasome inhibitors |
| TW200936143A (en) * | 2007-11-13 | 2009-09-01 | Protez Pharmaceuticals Inc | Beta-lactamase inhibitors |
| AR075090A1 (es) * | 2008-09-29 | 2011-03-09 | Millennium Pharm Inc | Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden. |
| CA2791651C (en) * | 2010-03-01 | 2019-08-20 | Onyx Therapeutics, Inc. | Compounds for immunoproteasome inhibition |
| JP6129203B2 (ja) * | 2011-12-22 | 2017-05-17 | アレス トレーディング ソシエテ アノニム | α−アミノボロン酸誘導体、選択性免疫プロテアソーム阻害剤 |
| WO2014086664A1 (en) * | 2012-12-03 | 2014-06-12 | F. Hoffmann-La Roche Ag | Substituted triazole boronic acid compounds |
| ES2873000T3 (es) | 2014-10-01 | 2021-11-03 | Merck Patent Gmbh | Derivados del ácido borónico. |
| CN107108660B (zh) | 2014-10-01 | 2020-09-15 | 默克专利股份公司 | 硼酸衍生物 |
| JP6662865B2 (ja) | 2014-10-01 | 2020-03-11 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | ボロン酸誘導体 |
-
2015
- 2015-10-01 KR KR1020177011646A patent/KR20170062518A/ko not_active Withdrawn
- 2015-10-01 SG SG11201702620SA patent/SG11201702620SA/en unknown
- 2015-10-01 JP JP2017518064A patent/JP6896618B2/ja not_active Expired - Fee Related
- 2015-10-01 CA CA2963198A patent/CA2963198A1/en active Pending
- 2015-10-01 MX MX2017004043A patent/MX2017004043A/es unknown
- 2015-10-01 CN CN201580053454.8A patent/CN107074885B/zh not_active Expired - Fee Related
- 2015-10-01 EP EP15800714.6A patent/EP3201208B1/en active Active
- 2015-10-01 US US15/516,422 patent/US10253049B2/en active Active
- 2015-10-01 RU RU2017115191A patent/RU2017115191A/ru not_active Application Discontinuation
- 2015-10-01 AU AU2015327412A patent/AU2015327412B2/en not_active Ceased
- 2015-10-01 WO PCT/EP2015/001931 patent/WO2016050356A1/en not_active Ceased
- 2015-10-01 ES ES15800714T patent/ES2876287T3/es active Active
- 2015-10-01 BR BR112017006349A patent/BR112017006349A2/pt not_active IP Right Cessation
-
2017
- 2017-03-21 IL IL251299A patent/IL251299A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2017004043A (es) | 2017-07-04 |
| IL251299A0 (en) | 2017-05-29 |
| WO2016050356A1 (en) | 2016-04-07 |
| JP2018502048A (ja) | 2018-01-25 |
| AU2015327412B2 (en) | 2020-01-16 |
| SG11201702620SA (en) | 2017-04-27 |
| CN107074885A (zh) | 2017-08-18 |
| AU2015327412A1 (en) | 2017-05-18 |
| US10253049B2 (en) | 2019-04-09 |
| ES2876287T3 (es) | 2021-11-12 |
| CN107074885B (zh) | 2020-11-27 |
| KR20170062518A (ko) | 2017-06-07 |
| JP6896618B2 (ja) | 2021-06-30 |
| CA2963198A1 (en) | 2016-04-07 |
| EP3201208A1 (en) | 2017-08-09 |
| US20180105538A1 (en) | 2018-04-19 |
| RU2017115191A3 (enExample) | 2019-02-12 |
| RU2017115191A (ru) | 2018-11-06 |
| EP3201208B1 (en) | 2021-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112017006368A2 (pt) | derivados de ácido borônico | |
| BR112017006349A2 (pt) | derivados de ácido borônico | |
| MX372823B (es) | Derivados de ácido borónico. | |
| MX2017004046A (es) | Derivados de acido boronico. | |
| EA201792205A1 (ru) | Гетероциклические соединения как ингибиторы lsd1 | |
| BR112016029333A2 (pt) | síntese de compostos de carbamoilpiridona policíclico | |
| MX377273B (es) | Ciclopropilamina como inhibidor de la desmetilasa 1 específica de lisinas (lsd1). | |
| BR112017006253A2 (pt) | novos compostos | |
| MX2016012829A (es) | Inhibidores de biaril cinasa. | |
| BR112017005266A2 (pt) | inibidores de mk2 e uso dos mesmos | |
| EA201891246A1 (ru) | Способ маркирования подложки | |
| BR112016014020A8 (pt) | moduladores de tetra-hidropiridopirazinas de gpr6. | |
| MX2020000386A (es) | Inhibidores heterociclicos de la cinasa atr. | |
| BR112016024533A2 (pt) | derivados de amino pirazina como inibidores de fosfatidilinositol 3-cinase | |
| MX2017001352A (es) | Derivados de pirrolidinona como inhibidores de metionina aminopeptidasa 2 (metap-2). | |
| CL2016001349A1 (es) | Uso de derivados de bencimidazol-prolina | |
| BR112015019624A2 (pt) | quinazolinas como inibidores de quinase | |
| BR112016018851A8 (pt) | processo para fornecer um composto de fórmula (iv) | |
| MX2016008259A (es) | Metodo de proceso para inhibidores de fosfatidilinositol 3-cinasa. | |
| BR112017013093A2 (pt) | processos para a preparação de um composto de diariltio-hidantoína | |
| BR112018013271A2 (pt) | composições e métodos para detectar e tratar câncer de ovário | |
| BR112016028022A2 (pt) | compostos de sulfonamida e seus usos como inibidores de stat5 | |
| MA39824A (fr) | Composés azole amido-substitués | |
| EP3498275C0 (en) | Use of known compounds as d-amino acid oxidase inhibitors | |
| MX373325B (es) | Nuevos compuestos de sulfonilaminobenzamida. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2598 DE 20-10-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |